Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$6.27B
sum of reported positions
Reported positions
833
Changes vs prior quarter
994
141 new · 267 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 299 measured positions in 6 quarters, the typical new or larger position finished −3.3 pts against the S&P 500 and 39% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 1.05M | $146M | 2.3% | |
| 333K | $83.8M | 1.3% | |
| 223K | $76.6M | 1.2% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.

Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $6.73B | $6.27B |
| Positions | 959 | 833 |
| Biggest line | — | Intel 2% |
| 957K |
| $74.9M |
| 1.2% |
| 403K | $73M | 1.2% |
| 696K | $71.2M | 1.1% |
| 76K | $70.7M | 1.1% |
| 176K | $69.9M | 1.1% |
| 514K | $69.6M | 1.1% |
| 922K | $68.6M | 1.1% |
| 1.66M | $68.6M | 1.1% |
| 65K | $68.2M | 1.1% |
| 396K | $66.5M | 1.1% |
| 680K | $65.3M | 1.0% |
| 236K | $65.1M | 1.0% |
| 409K | $62M | 1.0% |
| 660K | $60.5M | 1.0% |
| 571K | $59.1M | 0.9% |
| 151K | $54.8M | 0.9% |
| 849K | $54.5M | 0.9% |
| 185K | $54.3M | 0.9% |
| 1.57M | $50.2M | 0.8% |
| 642K | $49.9M | 0.8% |
| 176K | $49.9M | 0.8% |
| 268K | $48.2M | 0.8% |
Granite Ridge Resources (GRNT)
14K → 224K shares (+1513%)
HealthStream, Inc. (HSTM)
58K → 35K shares (−39%)
CorVel Corporation (CRVL)
6,905 → 15K shares (+117%)
FormFactor, Inc. (FORM)
85K → 5,850 shares (−93%)
Cable One (CABO)
23K → 18K shares (−23%)
Krystal Biotech (KRYS)
4,104 → 2,495 shares (−39%)
Diamondback Energy (FANG)
138K → 5,255 shares (−96%)
Fate Therapeutics (FATE)
338K shares
Central Pacific Financial Corp. (CPF)
32K → 24K shares (−27%)
Geopark (GPRK)
16K → 99K shares (+515%)
Citi Trends (CTRN)
15K shares
TTM Technologies (TTMI)
22K → 4,730 shares (−79%)
Lenz Therapeutics (LENZ)
154K shares
Intrepid Potash (IPI)
34K → 27K shares (−20%)
Shutterstock (SSTK)
78K → 62K shares (−21%)
MGE Energy, Inc. (MGEE)
11K shares
Ardent Health (ARDT)
43K → 88K shares (+105%)
Infinity Natural Resources (INR)
12K → 67K shares (+451%)
Ibotta (IBTA)
25K shares
Kinsale Capital Group (KNSL)
2,555 shares
CVR Partners, LP (UAN)
2,133 → 7,539 shares (+253%)
Magnera (MAGN)
89K → 71K shares (−21%)
Tonix Pharmaceuticals Holding (TNXP)
65K shares
Wabash National (WNC)
89K → 61K shares (−32%)
Peabody Energy, Inc. (BTU)
69K → 35K shares (−49%)